The Recall Desk
HighFDA (Devices)·Z-0777-2024·Announced 2024-01-31

Ultrasound Gel Sterility Cannot Be Guaranteed — FDA Recall

Turkuaz Saglik Hizmetleri is recalling over 4.9 million units of sterile ultrasound gel (REF 126590) because manufacturer cannot guarantee its sterility. Affected products in Illinois and Hong Kong should not be used.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: This FDA Class II recall involves a sterile medical device where sterility cannot be guaranteed, creating a risk-of-harm to patients. No illnesses or injuries have been reported, and the hazard is theoretical. Per the rubric, this qualifies as High (3).

Plain-English summary

Turkuaz Saglik Hizmetleri Medikal Temizlik Kim. Ur. San. ve Tic. A.S. is recalling approximately 4.9 million units of MEDLINE sterile ultrasound gel (REF 126590, 0.70 FL oz / 20 mL, packaged in quantities of 50). The product carries CE 2292 marking.

The manufacturer cannot guarantee the sterility of the product. Because ultrasound gel is classified as a sterile medical device, non-sterile product poses a risk of infection if applied to patients, particularly in clinical settings.

The recalled gel was distributed within the United States to Illinois and internationally to Hong Kong. Affected lot numbers include: SJ10091019, SJ22111019, SJ01041120, SJ25081020, SJ25061020, SJ20111020, SJ11021021, SJ24061021, SJ03061021, SJ14071021, SJ20091021, SJ09091021, and SJ06022023.

Healthcare providers and consumers who have the recalled product should discontinue use and contact the manufacturer or their supplier. No illnesses or injuries related to this product have been reported. The FDA classified this recall as Class II.

The recalled product

Product
REF: 126590, MEDLINE, STERILE ULTRASOUND GEL, 0.70 FL oz. (20 mL), QTY: 50, STERILER, CE 2292
Manufacturer
Turkuaz Saglik Hizmetleri Medikal Temizlik Kim. Ur. San. ve Tic. A.S.
Hazard
  • sterility-failure
  • infection-risk

Distribution

Distribution scope not specified by the agency.